Cryopreserved Umbilical Cord Mesenchymal Stem Cells Show Comparable Effects to Un-Cryopreserved Cells in Treating Osteoarthritis
Cell Transplantation · 2025
DOI: 10.1177/09636897241297631 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cell Transplantation, 2025. Verfasst von Bo Yan und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Osteoarthritis, Cryopreservation, Umbilical Cord. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Zhejiang Province Postdoctoral Scientific Research Merit-based Funding Project, Zhejiang Chinese Medical University Scientific Research Project Fund.
Abstract (Originalsprache)
Non-cryo and hypothermic preservations are two available options for short-term storage of living cells. For long-term cell storage, cryopreservation is an essential procedure as it prolongs the storage time, allowing for the transport and testing of cells, as well as the establishment of cell banks. But it is unclear whether cryopreservation reduces the therapeutic effects of human umbilical cord mesenchymal stem cells (hucMSCs) on osteoarthritis (OA). To investigate this, we compared the basic biological characteristics and the anti-OA efficacy of un-cryopreserved hucMSCs (UC-MSCs) and cryopreserved hucMSCs (C-MSCs). A mono-iodoacetate-induced rat OA model was established to evaluate the anti-OA properties of UC-MSCs and C-MSCs. And the conditioned medium of UC-MSCs (UC-CM) and cell freezing medium of C-MSCs (C-CFM) were collected for the mechanism study. No significant differences were found between UC-MSCs and C-MSCs in cell viability, immunophenotype, and trilineage differentiation capacity. In vivo, UC-MSCs and C-MSCs exhibited similar cartilage-repairing effects by attenuating pain and alleviating pathological changes in OA rat joints. In vitro, C-CFM and UC-CM promoted the proliferation of chondrocytes, improved the expression of anabolism-related molecules ( Col2, COL2, and SOX9), and decreased the expression of catabolism-related molecules ( Adamts5, Mmp13, Il6, COL10, and MMP13). These results indicated that UC-MSCs and C-MSCs had comparable anti-OA effects, and cryopreservation did not alter the anti-OA capability of hucMSCs, which provides further support for clinical use of C-MSCs in treating OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
- Cell Resource Bank and Integrated Cell Preparation Center of Xiaoshan District, Hangzhou Regional Cell Preparation Center (Shangyu Biotechnology Co., Ltd), Hangzhou, China.
ORCID-Profile: Le Guo
Förderung
- Zhejiang Province Postdoctoral Scientific Research Merit-based Funding Project
- Zhejiang Chinese Medical University Scientific Research Project Fund
Zitieren
APA
Yan, B., Chen, H., Yan, L., Yuan, Q., & Guo, L. (2025). Cryopreserved Umbilical Cord Mesenchymal Stem Cells Show Comparable Effects to Un-Cryopreserved Cells in Treating Osteoarthritis. Cell Transplantation. https://doi.org/10.1177/09636897241297631
Vancouver
Yan B, Chen H, Yan L, Yuan Q, Guo L. Cryopreserved Umbilical Cord Mesenchymal Stem Cells Show Comparable Effects to Un-Cryopreserved Cells in Treating Osteoarthritis. Cell Transplantation. 2025. doi:10.1177/09636897241297631
BibTeX
@article{Yan2025,
author = {Yan, Bo and Chen, Huixin and Yan, Li and Yuan, Qiang and Guo, Le},
title = {Cryopreserved Umbilical Cord Mesenchymal Stem Cells Show Comparable Effects to Un-Cryopreserved Cells in Treating Osteoarthritis},
journal = {Cell Transplantation},
year = {2025},
doi = {10.1177/09636897241297631}
}
EUVIMED